Sentinext Therapeutics Sdn Bhd
Latest round
- Series B
Last raised
- Jan 2018
Total raised
- $28M
Investors
- 6
About Sentinext Therapeutics Sdn Bhd
Sentinext Therapeutics Sdn Bhd was founded in 2009 and operates from Malaysia.com, which caters to a global audience in various industries such as technology, finance, healthcare, and education.com specializes in offering premium domain names, with a focus on the technology and innovation sectors.com, aims to significantly enhance a company's online identity and visibility, enabling effective audience engagement across multiple industries.70.09 million to expand its product offerings and enhance its market reach. Future strategies include the development of new premium domain names tailored to emerging industries and expanding into new geographic markets, although specific timelines and regions for this expansion have not been disclosed.
Who invested in Sentinext Therapeutics Sdn Bhd
6 investors across 4 rounds
See all investors in Sentinext Therapeutics Sdn Bhd
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sentinext Therapeutics Sdn Bhd
Who invested in Sentinext Therapeutics Sdn Bhd?
Sentinext Therapeutics Sdn Bhd has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sentinext Therapeutics Sdn Bhd raised?
Sentinext Therapeutics Sdn Bhd has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Sentinext Therapeutics Sdn Bhd last raise money?
Sentinext Therapeutics Sdn Bhd's most recent round on record is a Series B, in Jan 2018.
What does Sentinext Therapeutics Sdn Bhd do?
Sentinext Therapeutics Sdn Bhd was founded in 2009 and operates from Malaysia.
Where is Sentinext Therapeutics Sdn Bhd headquartered?
Sentinext Therapeutics Sdn Bhd is headquartered in Malaysia.
Which VCs invest in companies like Sentinext Therapeutics Sdn Bhd?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sentinext Therapeutics Sdn Bhd's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sentinext Therapeutics Sdn Bhd? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.